13 December 2012

Africa: Focusing On Malaria Drug Discovery

Photo: Laura Newman/PATH
Mosquitoes

MMV guest edits a special focus issue on malaria drug discovery in Future Medicinal Chemistry

The December issue of Future Medicinal Chemistry will be dedicated to antimalarial drug discovery and guest edited by Jeremy Burrows, MMV's Head of Discovery.

"Interest in malaria drug research has undergone radical renewal in the past decade," said Jeremy. "The disease places an unacceptably huge burden on vulnerable populations around the world. It is clear that new tools to control and eliminate this fatal disease are urgently needed. This issue of Future Medicinal Chemistry reflects this urgency and brings to light a broad spectrum of exciting research focused on malaria."

The issue includes numerous contributions from leading experts around the world who reveal the latest thinking, from target-based drug discovery through to high-throughput screening of the whole cell. Contributors also explain the growing appreciation that malaria eradication will require novel and innovative interventions to block transmission of the parasite and radically cure relapsing malaria.

"The Malaria Eradication Agenda challenge is ... tough," continued Jeremy. "And so it's reassuring to know that researchers and drug developers are at their innovative best in malaria drug research, seeking drugs that not only cure, but also block transmission and counter resistance."

All articles from this issue will be free to access until the end of March 2013 from the journal's website.

Ads by Google

Copyright © 2012 Medicines for Malaria Venture. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

InFocus

Speeding Up Malaria Vaccine Development

Mosquitoes

A recently announced follow-on collaboration between the PATH Malaria Vaccine Initiative (MVI) and Invovio Pharmaceuticals will test whether a novel vaccine approach that combines ... Read more »